Last reviewed · How we verify

NCT05418504

Study of Tramadol Addiction Impact on Dental Anesthesia Success Among Algerian Males

Status unknown Phase 4 Last updated 16 June 2022
What this trial tests

Phase 4 trial testing Dental anesthesia in Dental Procedure in 400 participants. Status unknown.

Timeline
1 May 2022
Primary endpoint
1 August 2022
1 August 2022

Quick facts

Lead sponsorFuture University in Egypt
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment400
Start date1 May 2022
Primary completion1 August 2022
Estimated completion1 August 2022
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Future University in Egypt

Who can join

Adults 18 to 65, male only, with Dental Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dental anesthesia is considered by far one of the main procedures in dentistry; the performance of a good dental anesthesia with a correct technique is paramount in controlling pain, facilitating the work of the dentist and gaining the confidence and cooperation of the patient Tramadol is an FDA-approved medication for pain relief indicated mainly for moderate to severe pain, it is an opioid with 6 hours Half-Life and different dosages as 50mg, 100mg, 200mg and 300mg. Due to possible abuse and addiction potential, limitations to its use should be for pain that is refractive to other pain medication, such as non-opioid pain medication, unfortunately, the almost non-existent of censorship in Algeria and the disorderly framing made the obtain of tramadol as a medicine very easy which has led to a very alarming abuse of this drug

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dental anesthesia

Trials testing the same drug.

Other Future University in Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05418504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing